Little is known about the molecular background to senescence in T-lymphocytes. In ®broblast systems replicative senescence has been shown to correlate with a number of changes in the expression of the proteins normally regulating progression through the G1 phase of the cell cycle, and recently the Ink4 inhibitor p16 was implicated as a central regulator of replicative senescence in human ®broblasts. It has, however, been claimed that p16 is not expressed in T-lymphocytes. In the present study we have analysed G1 regulating proteins in ageing human T-lymphocytes. We show that PHA and IL-2 stimulated T-lymphocytes cease to proliferate after around 20 population doublings, these cells can not thereafter be restimulated to growth, and were also found to exhibit markers for senescence. We found that Tlymphocytes accumulate p16 and p15 protein during successive population doublings and display high levels of these proteins as they enter into replicative senescence. There was also an increased binding of p16 to the Cdk6 kinase in senescent cells, and a decreased Cdk6 as well as Cdk2 kinase activity. The levels of other G1 regulating proteins were also altered in the senescent cells, such as slightly elevated levels of p21/WAF1, and downregulation of Cdk2 and cyclinD3. The levels of p27/ Kip1 is down regulated in proliferating cells but rise to approximately 15% of the levels in un-stimulated quiescent cells. As a high proportion of T-cell childhood acute lymphoblastic leukaemias have deletions of both p15 and p16, our data suggest that inactivation of these genes makes it possible for leukemic cells to avoid senescence.
Introduction
As described by Hay¯ick more than 30 years ago, human cells have a limited lifespan and will, after a de®ned number of population doublings, enter a nonreplicative but metabolically active state termed senescence (Hay¯ick, 1965) . The fact that cell cultures derived from human tumours often divide inde®nitely, has lead to the hypothesis that cellular senescence is a tumour suppressor mechanism (Smith and PereiraSmith, 1996) . During replicative senescence, cells arrest in the G1 phase of the cell cycle. With the discovery of a number of proteins normally regulating the cell cycle and G1 progression, some of the molecular events involved in replicative senescence have been identi®ed (Smith and Pereira-Smith, 1996) .
Ordered progression through the cell cycle is mediated by the sequential activation of a family of serine/threonine protein kinases. These kinases are composed of a regulatory subunit, the cyclin, and a catalytic subunit, the cyclin dependent kinase (Cdk). When activated, these kinases will phosphorylate their substrates in order for the cell cycle to proceed. In mammalian cells, the early G1 phase is regulated by the D-cyclins together with their catalytic partners Cdk4 and Cdk6. The cyclinE-Cdk2 complex is activated in late G1, preceding the initiation of Sphase (reviewed in GranÄ a and Reddy, 1995) . Recently a number of inhibitors of these Cdk complexes have been identi®ed, falling into two categories (GranÄ a and Reddy, 1995; Hirama and Koeer, 1995) . The Cip/ Kip family including p21, p27 and p57 are inhibitory proteins with a broad speci®city, capable of binding to Cdk-complexes containing cyclins D, E or A. By contrast, members of the Ink4 family, p15, p16, p18 and p19, interact with the Cdk4 and Cdk6 kinases only, thereby interfering with the binding of the D type cyclins.
One of the critical substrates for the G1 speci®c cyclin dependent kinases is the retinoblastoma tumour suppressor gene product (pRb). Phosphorylation of pRb by the cyclin-Cdk complexes is accompanied by release and activation of transcription factors of the E2F family. Active E2F binds to the promoters of essential S-phase genes and activate their transcription (La Thangue, 1996) .
The Ink4 locus, located at band 21 on the short arm of chromosome 9, comprises the highly homologous p15 and p16 genes as well as an alternatively spliced p16 transcript called p16E1b (Stone et al., 1995b) . The p16 INK4A gene, also referred to as CDKN2A, CDKN2A or MTS1, encodes a 156-amino acid protein which was identi®ed, cloned and characterized by its interaction with Cdk4 (Serrano et al., 1993; Hannon and Beach, 1994) . Like the other Ink4 proteins it contains multiple ankyrin repeats, presumably involved in proteinprotein interaction. Over-expression of p16 in cells with functional pRb results in G1 arrest, but is without eect in cells lacking pRb (Guan et al., 1994; Serrano et al., 1995) . Recently, p16 has been implicated as a key regulator in the senescence program, since ageing ®broblasts increase their p16 content in proportion to the number of population doublings (Hara et al., 1996) . The stimulation of p16 transcription through loss of pRb repression coupled with a high stability of the p16 transcript are two factors suggested to contribute to this accumulation (Hara et al., 1996) . p15
INK4B
, also referred to as MTS2, on the other hand, was originally described as a TGFb inducible gene and is involved in TGFb-induced G1 arrest (Hannon and Beach 1994; ReynisdoÂ ttir et al., 1995) , but has also been shown to be upregulated in G1 arrested cells following interferon-a treatment (Sangfelt et al., 1997a) . p15 has to our knowledge not previously been shown to be involved in senescence.
The p16
INK4A
/p15 INK4B locus has been found to be deleted in established cell lines, primary cells from solid tumours as well as leukaemias (reviewed in Heyman and Einhorn, 1996) . A vast amount of data has accumulated implicating loss of p16 function in a variety of tumours. Point mutations and small deletions are common in for instance pancreatic adenocarcinomas and familiar melanomas (Caldas et al., 1994; Kamb et al., 1994; Hussussian et al., 1994) . Large homozygous deletions which in most cases also involve p15
INK4B
, are commonly detected in malignant gliomas and acute lymphoblastic leukaemias (ALL) (Sonoda et al., 1995; Rasool et al., 1995) . Methylation of the Ink4 locus has been found in breast and colon cancers, exemplifying another possible mechanism for inactivation. No inactivating point mutations have been found in the p15 gene and although it is deleted in several malignancies it has not clearly been demonstrated to be a tumour suppressor gene (Stone et al., 1995a) . Selective methylation of the p15 gene has been demonstrated in ALL cells (Herman et al., 1996) , but the signi®cance of this ®nding remains unclear. Knockout mice carrying targeted deletions of the Ink4 locus inactivating both the p16 protein and p19 ARF , the murine protein encoded by the p16E1b transcript, are viable but develop spontaneous tumours at an early age and are highly sensitive to carcinogenic treatment (Serrano et al., 1996) .
In this study, the expression of G1-phase regulatory proteins and the functional properties of Cdk-cyclin complexes have been studied in T-cells during their activation, proliferation and subsequent senescence utilising the well established system of stimulating normal resting T-lymphocytes by sequential addition of PHA and IL-2 .
Results

T-lymphocyte stimulation, proliferation and senescence
Following PHA-stimulation for 72 h 1 ± 2% of the lymphocytes entered S-phase (Figure 1, day 3) . Addition of IL-2 at day 3, allows the majority of cells to enter into a proliferative exponential growthphase with about 90% of actively proliferating cells as judged by BrdU labelling (data not shown), and an Sphase fraction of 20 ± 30% from around day 6 ( Figure  1 ). At day 18 ± 20 the cells start to re-accumulate in G1 despite re-addition of IL-2, and around day 20 ± 30 more than 90% of the cells were found in the G1-phase (Figure 1 ).
Characterization of senescence
The timepoint for reaccumulation in G1 varied somewhat, from 20 ± 30 days of culture, probably re¯ecting age dierences between the dierent donors Figure 1 Flow cytometry analysis of DNA content in T-lymphocytes at the indicated timepoints after addition of PHA at day 0. IL-2 was added to the cultures at day 3 and additionally every third day as described in Materials and methods. The percentage of cells with a G1 DNA-content is indicated p16 and p15 in T-lymphocyte senescence S Erickson et al (Campisi, 1996) . In order to demonstrate the senescent state of these cells, several experiments were performed. Restimulation of the cells with two dierent concentrations of PHA following 21 days of culture did not in either case result in any detectable reinduction of proliferation (data not shown), which is in agreement with previous models of T-cell senescence (Perillo et al., 1993; Eros, 1996) . The expression of CD28, which has previously been described as a marker for senescence in T-lymphocytes (Eros, 1996) , was studied by¯ow cytometry at dierent timepoints. At the initiation of the culture the majority of the cells expressed CD28 (Figure 2a ), whereas the non-proliferating cells at the end of the culture had virtually abolished their expression of this marker (Figure 2b ). b-gal (b-gal) staining at pH 6.0, referred to as Senescence-Associated b-galactosidase (SA-b-gal), has been shown to be a reliable marker for senescence in other cellular systems by (Dimri et al., 1995; Uhrbom et al., 1997) . We found that 1 ± 2% of un-stimulated T-cells have detectable SA-b-gal activity. At day 6, when the majority of cells are proliferating, there is no change in the proportion of SA-b-galpositive cells, as again only 1 ± 2% show a positive staining. However, 90 ± 95% of cells from aged cultures (day 30) expressed signi®cant levels of SA-b-gal activity. Furthermore, double staining of BrdU labelled cells with DAPI and ourscent anti-BrdU antibodies and subsequent analysis by¯ow cytometry, showed that the length of the cell cycle during maximum proliferation was less than 24 h (data not shown), which would mean that the Tlymphocytes have gone through some 15 ± 25 PD at the timepoint when replicative senescence occurs, which is in agreement with previous data (Perillo et al., 1993) . Together these data strongly implicate that the cells obtained at day 21 and later timepoints are to consider as senescent.
Regulation of Ink4 inhibitory proteins during T-lymphocyte activation and senescence
Quiescent T-lymphocytes, or cells stimulated by PHA alone, do not express p16 protein at detectable levels. However, at around 72 h after IL-2 addition a faint band appears, which gradually increases as the cells enter into logarithmic growth-phase. The amount of p16 protein then continue to increase with increasing number of population doublings ( Figure 3a) . The accumulation rate of p16 is relatively constant during the proliferative phase and the highest levels are found in senescent cells (Figure 3a and b). Similar results were obtained with immunostaining for p16 expression in individual cells; p16 could not be detected in unstimulated, quiescent cells. A uniformly low expression was detected during the early proliferative phase, whereas the senescent cells showed uniform strong p16 staining in the cytoplasm (data not shown).
In some contrast to p16, the p15-protein is expressed at low levels in un-stimulated cells, but similarly to p16 it accumulates in proliferating cells (Figure 3a) . The accumulation kinetics of p15 is, however, slightly dierent. There is a lag-time of approximately 9 days before the accumulation begins and the levels reach a plateau around days 14 ± 16, which is somewhat earlier than for p16 (Figure 3b ).
Regulation of the Cip/Kip inhibitors during T-lymphocyte activation and senescence
High levels of p27 is a hallmark of un-stimulated Tlymphocytes resting in G 0 (Nourse et al., 1994; , 1994) . p27 protein levels were not detectably aected by PHA treatment but rapidly decreased following IL-2 stimulation, with very low expression levels in proliferating cells (Figure 4a ). Pre-senescent (days 16 ± 21) and senescent cells re-accumulated p27, but the levels in the senescent culture only reached around 15% of the level in the un-stimulated cells.
p21 was expressed at very low levels in un-stimulated and proliferating cells, but was weakly up-regulated in senescent cells (Figure 4a ).
Phosphorylation pattern of pRb and p130
The expression and phosphorylation pattern of pRb and p130 was examined by Western blotting during the dierent stages of lymphocyte stimulation. Un-stimulated cells do not express detectable levels of pRb. Following PHA-stimulation a faint band corresponding to the hypophosphorylated form of pRb can be detected. Hyperphosphorylated pRb appears about 72 h after IL-2 stimulation and the level of pRb increases during the proliferative growth-phase, reaching a maximum at day 9. The pRb levels remain high during senescence, but in the senescent cells pRb is mainly found in the hypophosphorylated active form (Figure 4c ).
p130 is expressed both in un-stimulated and PHAstimulated cells, mainly in its hypophosphorylated form. The p130 protein becomes up-regulated and shifts to the hyperphosphorylated form around 72 h after IL-2 addition, reaching its maximum levels at day 9. In presenescent and senescent cells p130 becomes slightly downregulated, and in these cells it is found in the hypophosphorylated form (Figure 4c ). The monoclonal p130 antibody used detected a band of slightly higher molecular weight than the p130 bands (Figure 4c) , that was not regulated during the experiment. To rule out that it was a p130 band unaected by T-cell proliferation, a second polyclonal antibody was used. The same p130 band pattern was obtained with this antibody but the higher molecular weight band could not be detected, making it most likely that it represents an unspeci®c band (data not shown).
Regulation of G1 Cdk expression and activity during T-lymphocyte activation and senescence
Un-stimulated T-lymphocytes contain very low levels of Cdk2 protein and exclusively in its slowly migrating, inactive form. The faster migrating, active form is detected 72 h after IL-2 stimulation, and the amount of Cdk2 is also dramatically increased at this point. In senescent cells, Cdk2 was slightly down-regulated and mainly found in its inactive form (Figure 4b ).
Cdk2 associated kinase activity, which is ratelimiting for the progression into S-phase in mammalian cells, was assayed using histon H1 as a substrate at dierent time-points before and after stimulation with IL-2. In the senescent cells, Cdk2 kinase activity was reduced by approximately 50% compared with actively proliferating T-lymphocytes ( Figure 5 ).
The Cdk6 kinase was expressed at low levels in unstimulated and PHA stimulated cells. Similarly to Cdk2, there was a pronounced up-regulation in the expression of this protein around seventy-two hours after IL-2 addition, and the levels remained high also in presenescent and senescent cells (Figure 4b ). The high p16 levels in senescent cells was accompanied by an increased binding of this inhibitor to Cdk6 as detected by immunoprecipitation followed by Western blotting (Figure 6 ). However, no increase in Cdk6 bound p15 could be detected in senescent cells. The phosphorylating activity of this kinase increased as the cells started to proliferate, whereas the senescent cells displayed approximately 25% of the Cdk6 kinase activity found in proliferating cells ( Figure 5 ). Thus, despite high Cdk6 protein levels in the senescent cells, Figure 4 Western blot analysis of (a), p27 and p21 (b), Cdk2 and Cdk6 (c), pRb and p130, protein expression for the indicated timepoints after stimulation. Stimulation was performed as described in Materials and methods. * indicates an unspeci®c band which occurs when hybridizing with the monoclonal p130 antibody Figure 5 Cdk2 and Cdk6 associated kinase activity in actively proliferating (day 9) and senescent T-lymphocytes (day 21). For Cdk2 associated kinase activity, 50 mg of whole protein extract was used and activity of immunoprecipitated Cdk2 complexes was assayed using histone H1 as substrate. For determination of Cdk6 associated kinase activity, 200 mg of whole protein extract was used and the activity of immunoprecipitated Cdk6 complexes was assayed using GST-Rb as substrate. Quantitation of kinase activity was performed using scanning densitometry. Proliferating cells were given an arbitrary value of 100% p16 and p15 in T-lymphocyte senescence S Erickson et al the increase in Cdk6 bound p16 resulted in a sharp decrease in kinase activity. Similar results were obtained studying cyclin D3 associated kinase activity (data not shown).
As for Cdk2 and Cdk6, the Cdk4 kinase was expressed at low levels in un-stimulated and PHA stimulated cells. Following IL-2 addition there was a slight increase in the Cdk4 expression. The levels increased somewhat further during maximal proliferation and then gradually declined to a low level in the senescent cells (data not shown). Repeated Cdk4-kinase assays did not show any conclusive dierences in activity between proliferating and senescent cells, possibly due to the relatively low amounts of Cdk4 protein, and diculties in measuring Cdk4 activity with the currently available antibodies as experienced by others (ReynisdoÂ ttir et al., 1995; Hannon and Beach, 1994) .
The dierent cyclins active at the G1-S transition were also regulated during T-cell activation and senescence ( Figure 7 ). Cyclin D3 was not expressed in resting T-lymphocytes. Forty-eight hours after IL-2 addition a faint band appeared and at day 9 full expression was achieved. The expression of cyclin D3 increased to its maximum in the proliferating cells, whereas the senescent cells showed low cyclin D3 levels. Un-stimulated T-lymphocytes express low levels of cyclin E, but upon PHA stimulation this protein was expressed. CyclinE was further upregulated after IL-2 addition, reaching plateau levels at day 9. The protein levels of cyclin E remained high also in senescent cells (Figure 7 ).
Discussion
In recent years, attempts have been made to determine the molecular background to cellular senescence, primarily through studies on ®broblasts. Several groups have demonstrated that senescent cells arrest with a G1 DNA content, and express increased levels of p16, p21 and p53 (Hara et al., 1996; Alcorta et al., 1996; Rezniko et al., 1996; Atadja et al., 1995; Serrano et al., 1997) . p16 accumulates both in ®broblasts and uroepithelial cells as a consequence of the increasing number of population doublings, eventually leading to senescence. Also p21 accumulates in ageing ®broblasts but in contrast to p16, the levels drop in senescent cells (Alcorta et al., 1996) . Other molecular markers for ®broblast senescence are, lack of serum-dependent induction of c-fos (Seshadri and Campisi, 1990 ) and increased expression of the plasminogen activator inhibitor type-1 (PAI-1) gene .
Also T-lymphocytes have been demonstrated to enter senescence. The lifespan of a peripheral blood Tlymphocyte, initially stimulated with PHA and subsequently supplemented with IL-2, has been determined to be 23+7 cumulative population doublings, and only a minor fraction of these senescent cells re-enter the cell cycle when re-stimulated (Perillo et al., 1993; Eros, 1996) . In contrast to ®broblasts, few biomarkers have been de®ned for T-lymphocyte senescence, which has rather been determined by an inability of the Tlymphocytes to re-enter the cell cycle following renewed antigen stimulation (Eros, 1996) . However, a reduced expression of CD28 has previously been observed during T-lymphocyte senescence (Perillo et al., 1993) , an eect that was observed also in our system. Furthermore, we observed an induction of SA-b-gal activity in the aged Tlymphocytes, which has been shown to be a biomarker for senescence in other cellular systems (Dimri et al., 1995; Uhrbom et al., 1997) . This demonstrates that SAb-gal activity can be used also for analysing senescence in T-lymphocytes.
As replicative senescence is intimately coupled with a de®nite G1 arrest, we have in this study examined the regulation of dierent cell cycle regulating proteins implicated in G1 control and their activities during Tlymphocyte activation, proliferation and senescence. There are several reasons for performing this study on T-lymphocytes. Firstly, the vast majority of studies concerning the molecular mechanisms of replicative senescence have been performed in ®broblasts only. Secondly, T-lymphocytes are cells with a de®ned in vivo role, and are intermittently activated throughout the life of the organism as a response to antigen stimulation. Thirdly, the events taking place during replicative senescence are of great interest to tumour biologists, since the normal senescence machinery may be abrogated in malignant cells. These facts, together with the ®nding that a majority of T-cell childhood acute lymphoblastic leukaemias (T-ALL) have deletions of the Ink4 locus on chromosome 9, prompted us to investigate if and how p16/ p15 and other cell-cycle regulating proteins are controlled during T-lymphocyte senescence.
p16 does not seem to play an important role in quiescence, as it is not expressed in resting unstimulated T-lymphocytes. p16 is ®rst detected around Figure 6 The amount of p16 protein binding to Cdk6 in proliferating (day 9 after stimulation) and senescent T-lymphocytes (day 21 after stimulation). Coupled immunoprecipitation with polyclonal Cdk6 antibodies and immunoblotting with polyclonal Cdk6, and monoclonal p16 antibodies was performed from 1 mg of whole protein extract Figure 7 Western blot analysis of cyclinD3 and cyclinE protein expression for the indicated timepoints after stimulation. Stimulation was performed as described in Materials and methods p16 and p15 in T-lymphocyte senescence S Erickson et al 72 h after addition of IL-2, whereafter the cells exhibit a constant increase in p16 protein levels with increased number of population doublings. The appearance of p16 correlates well with the increased abundance of hyperphosphorylated pRb. The mechanism for p16 accumulation following increased number of population doublings is not fully understood. However, Hara and colleagues have in a ®broblast system shown that the p16 promotor contains an`Rb-element' which is not an E2F site, repressing p16 expression when pRb is hypophosphorylated and that this repression is released when pRb becomes hyperphosphorylated (Hara et al., 1996) . In the same study it was also shown that the p16 transcript is very stabile, and the authors suggest that these eects are responsible for the accumulation of p16 protein. Also, other yet unde®ned factors could in¯uence p16 protein accumulation, including additional regulatory elements in the p16 promotor and other mechanisms for pRb inactivation. Our results are in accordance with the model proposed by Hara and co-workers, implicating that p16 is a major contributor to senescence also in T-lymphocytes.
A previous study implicated that p15 expression is downregulated at the mRNA level in T-lymphocytes following activation (Lois et al., 1995) . In contrast to this study, we found that also p15 protein accumulates in the lymphocytes during the proliferative phase, reaching its highest levels in senescent cells. Low levels of p15 could also be detected in un-stimulated cells and the accumulation kinetics was similar to that of p16 (Figure 2b ). The p15 protein has previously been shown to be expressed in T-lymphocytes (Stone et al., 1995b) , but this is the ®rst study, to our knowledge, in which p15 accumulation has been demonstrated in senescent cells in a fashion similar to p16.
The data presented in this paper may explain one of the mechanisms behind replicative senescence in Tlymphocytes. The gradual accumulation of p15 and p16 following IL-2 stimulation may be responsible for the G1 arrest when a certain threshold level of these inhibitors has been reached. While the Ink4 protein products only inhibit the early G1 kinases, Cdk4 and Cdk6, the reaccumulation of p27 in the senescent cells could be a mechanism to ensure that also the remaining active forms of Cdk2 are inactivated. The fact that we only found an increased binding of p16 and not p15, to Cdk6 may indicate that these inhibitors target dierent kinases. p15 has been found to inhibit both the monomeric Ink4 kinases as well as the active cyclin associated enzyme, while p16 has only been shown to bind to the monomeric kinase (ReynisdoÂ ttir and MassagueÂ , 1997). p15 may target Cdk4 in the senescent T-cells. However, if so we were unable to detect this probably due to the low levels of Cdk4 (data not shown). These ®ndings are in accordance with results obtained in glioma cells stably transfected with p16, where p16 expressing cells were found to have a low expression of Cdk4 making it dicult to detect Cdk4/Ink4 complexes, whereas p16 binding to Cdk6 was readily detectable (Uhrbom et al., 1997) .
The involvement of the p15-/p16-pRb pathway in T-lymphocyte senescence is further supported by some studies on the eects of viral oncoproteins. The human T-cell leukaemia virus type-1 (HTLV-1) oncoprotein, Tax, which is crucial for transformation by HTLV-1, has recently been shown to bind and inactivate p16 by interacting with its ankyrin repeats, indicating a mechanism for the transforming abilities of this virus (Suzuki et al., 1996) . Furthermore, transfection of primary T-lymphocytes with SV40 large T, whose protein is known to abrogate the pRb pathway, delays the point of cellular senescence (Ryan et al., 1993) .
The p16 gene is commonly deleted in leukemic cells from T-ALL patients, and p15 is co-deleted in many of these cases (Rasool et al., 1995) . In addition to deletion, the p15 gene is preferentially hypermethylated at a 5' CpG island in some cases (Batova et al., 1997; Herman et al., 1996) . Taken together these data show that both p15 and p16 are altered in a majority of these malignant clones. Several groups have previously reported that p16 is not expressed in primary T-lymphocytes (Tam et al., 1994; Lois et al., 1995) ; a ®nding which has prompted the question why a malignant cell would inactivate a non-expressed gene. Our data not only show that these proteins are indeed expressed but also underlines the importance of these genes for senescence in T-cells and indicate that their role in malignant transformation may be through alteration of the senescence program.
Materials and methods
All dierent experiments were performed with cells from three to ®ve dierent donors, with two exceptions mentioned below. Furthermore, all data presented in the ®gures are derived from one representative experiment.
T-lymphocyte isolation and cell culture
Buy coats from ®ve healthy blood donors were heparinised, and mononuclear cells isolated by Lymphoprep gradient centrifugation (Nycomed, Oslo, Norway). Tlymphocytes were isolated as previously described (Ullberg et al., 1983) . In short, the fractionated cells were washed once in PBS, and the cellular pellet was resuspended in complete minimal essential medium (MEM) (MEM, supplemented with 10% heat inactivated AB + serum, 2 mM glutamine, 50 mg/ml of streptomycin and 50 mg/ml of penicillin), and incubated for 1 h on plastic dishes for depletion of adherent cells. The remaining cells in suspension were centrifuged and resuspended in prewarmed complete MEM. To deplete the cells in suspension of B-cells and remaining monocytes the cells were layered onto a nylon wool ®bre column and incubated at 378C for 45 min. Non-adherent cells were recovered by passing 20 ml of prewarmed complete MEM through the column. The recovered non-adherent cells were then incubated on plastic dishes over night. The cells recovered represent the resting un-stimulated population of T-lymphocytes used in the subsequent experiments. The puri®ed human Tlymphocytes were tested for purity before stimulation as described below.
The lymphocytes were seeded at a density of 10 6 cells per ml in complete MEM and kept in a humid incubator with 5% CO 2 . The cells were reseeded every third day and fresh medium was added. The resting T-lymphocytes were stimulated in a two stage process, by sequential addition of PHA and IL-2 for proliferation to start, by addition of 0.8 mg/ml of PHA (Sigma) for 72 h and subsequent addition of IL-2 at a concentration of 100 U/ml, as a proliferation signal ). IL-2 was then added to the cultures every third day. Senescent cultures were restimulated by readition of PHA (0.8 or 0.08 mg/ml) together with IL-2 (100 U/ml). 
DNA labelling and¯ow cytometric analysis
Fixation and analysis of DNA histograms was performed as previously described (Sangfelt et al., 1997a) . The presence of non-T-cells in the culture as well as senescence associated CD28 expression was determined by¯ow cytometry. These experiments were repeated with cells from two dierent donors. The following MoAbs were purchased from Becton Dickinson (Mountain View, CA) CD28, CD3, CD16, 56, CD14 and CD19. The cells were stained as follows and analysed in a FACScan¯ow cytometer using the Lysis II software. Statistics were calculated from ungated cell-population. 0.5610 6 cells were mixed with 10 ml¯uorochrome-conjugated antibody, incubated in the dark at 48C for 30 min and washed twice with PBS. Cells were resuspended in 1 ml PBS and analysed.
The cultures contained less than 5% (CD56 and CD 16 positive and CD3 negative) NK cells and less than 1% (CD19 positive) B-cells. The remaining 94% were CD3 positive. These proportions were not signi®cantly altered during the ®rst 7 days of culture.
BrdU labelling and subsequent¯ow cytometric analysis was performed as previously described (Sangfelt et al., 1997b) . Cells were eihter pulse labelled for 1 h with BrdU, washed twice in PBS and recultured in complete MEM for 2 ± 24 h, or labelled with BrdU for 48 h and then harvested.
Western blot analysis
Western blot analysis was performed essentially as previously described (ReynisdoÂ ttir et al., 1995) . Brie¯y, whole cell extracts were prepared by lysis through sonication in equal amounts of LSLD buer (50 mM HEPES at pH 7.4, 50 mM NaCl, 10% Glycerol, 0.1% Tween 20, 0.3 mM Na-orthovanadate, 50 mM NaF, 80 mm b-glycerophosphate, 20 mM Na-pyrosphosphate, 1 mM dithiothreitol (DTT) and 1 mM phenyl-methyl-sulphonyl ouride (PMSF), 10 mg/ml of leupeptin, 10 mg/ml of antipain, 100 mg/ml of benzamidine hydrochloride, 5 mg/ ml of aprotinin and 100 mg/ml of soybean trypsin inhibitor). Protein concentration was quantitated spectrophotometrically with a protein assay kit, according to the instructions of the manufacturer (Bio-Rad, Hercules, CA). 70 mg of protein was loaded in each well, and the proteins were resolved on a 8% (for detection of pRb and p130 proteins) or a 12% (for all other proteins) SDS ± PAGE and electroblotted to PVDF-membranes (Boehringer Mannheim GMbH, Germany) by semi-dry transfer. The ®lters were susbequently stained with Ponceau S (Sigma) 0.1% in 5% acetic acid to determine transfer eciency and even loading. All Western blot data presented derive from protein from one representative experiment transfered to two ®lters, one for pocket proteins and one for all other proteins. These ®lters were rehybridized with the indicated antibodies without intermediate stripping. Similar results were always obtained with protein extracts from the other donors. For protein detection the ®lters were hybridized with the following monoclonal antibodies (dilution); antipRb (1 : 1000), anti-p130 (1 : 2000), anti-p16 (1 : 500), antip21 (1 : 500), anti-p27 (1 : 2000), anti-Cdk2 (1 : 2000), anticyclinA (1 : 500) and anti-cyclinE (1 : 1000) and the following polyclonal antibodies; anti-p15 (1 : 200), antip130 (1 : 1000), anti-Cdk4 (1 : 1000), anti Cdk6 (1 : 2000) and anti-cyclinD3 (1 : 200). Antibody-antigen interaction of the monoclonal antibodies was detected by incubation with biotin-conjugated anti-mouse antibodies followed by incubation with horseradish peroxidase-linked streptavidin and subsequent detection by enhanced chemiluminescence (Amhersham, Aylesbury, UK). For polyclonal antibodies, incubation with horseradish peroxidase-conjugated antirabbit antibodies preceded the enhanced chemiluminescence reaction. pRb, p16, cyclinA, cyclinE, Cdk4 and Cdk6-antibodies were obtained from PharMingen (San Diego, CA), p21, p27, p130 and Cdk2 antibodies from Transduction Laboratories (Lexington, KY). p15, p130 and cyclin D3 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Immunoprecipitation and kinase assays
The same protein extracts were used for immunoprecipitation as for Western blots and was performed as previously described (Sangfelt et al., 1997a) . One mg of whole cell lysates were incubated with anti-Cdk4 or Cdk6 antibodies (kindly provided by Dr D Beach, Cold Spring Harbor; USA) for 1 ± 2 h at 48C. Immunocomplexes were then bound to protein-A-sepharose by incubation at 48C for 1 h and subsequently washed several times with LSLD buer. Immunoprecipitated proteins were resolved by separation on SDS ± PAGE, electroblotted to ®lters and hybridized with dierent antibodies as described above.
The Cdk2 kinase activity was assayed using histone H1 as a substrate. Cdk2-immunocomplexes were washed three times in kinase buer (50 mM Tris-HCl at pH 7.5, 10 mM MgCl 2 and 1 mM DTT). Washed complexes were resuspended in kinase buer and the enzyme activity was assayed by addition of 5 mg histone H1 (Sigma), 1 mM ATP and 5 mCi [g-32 P]ATP (5000 Ci/mmole) (Amersham Life Sciences), to a ®nal volume of 50 ml and incubated for 30 min at 308C. The reaction was stopped by addition of one volume of 26 SDS sample buer and boiling for 5 min. An aliquot was loaded on an 12% SDS ± PAGE and separated. The gel was dried and exposed to X-ray ®lm (Amersham Life Sciences).
Cdk6 and cyclinD3 kinase activity was assayed using 2 mg of GST-Rb (Santa Cruz Biotechnology, Santa Cruz, CA) as a substrate according to (Matsushime et al., 1994) , and analysed as described for Cdk2 kinase assays. The kinase assays were repeated with material from two dierent donors.
Immunohistochemistry p16 expression in individual cells was analysed in cytospin preparations. The detection was carried out with DAKO LSAB+ Kit, according the instructions of the manufacturer (DAKO, Carpinteria, CA).The p16 antibody (PharMingen, San Diego, CA) was diluted 1:100.
Senescence-associated b-galactosidase (SA-b-Gal) staining SA-b-gal activity was assayed in cytospin preparations as described (Dimri et al., 1995; Uhrbom et al., 1997) . Cells were judged positive by showing a blue perinuclear staining when viewed in a light-microscope. Three hundred cells were counted in several independent experiments and the percentage of positively staining cells was calculated.
Quantitation of band intensity
Hybridization signals were quantitated by scanning densitometry using an Ultroscan XL (Pharmacia LKB Biotechnology, Uppsala, Sweden).
